Document is current
Any future updates will be listed below
-
Authors
Ochi, Sae
Sonomoto, Koshiro
Nakayamada, Shingo
Tanaka, Yoshiya https://orcid.org/0000-0002-0807-7139
- License Information
-
More Information
Article History
Received: 18 October 2021
Accepted: 13 February 2022
First Online: 1 March 2022
Declarations
:
: This study was carried out in compliance with the Helsinki Declaration and was approved by the ethics review board of the University of Occupational and Environmental Health, Japan (approval number#04-23). Informed consent was obtained from all patients of the FIRST Registry.
: YT has received speaking fees and/or honoraria from Daiichi-Sankyo, Eli Lilly, Novartis, YL Biologics, Bristol-Myers, Eisai, Chugai, Abbvie, Astellas, Pfizer, Sanofi, Asahi Kasei, GSK, Mitsubishi-Tanabe, Gilead, and Janssen; research grants from Abbvie, Mitsubishi-Tanabe, Chugai, Asahi Kasei, Eisai, Takeda, and Daiichi-Sankyo; and consultant fee from Eli Lilly, Daiichi-Sankyo, Taisho, Ayumi, Sanofi, GSK, and Abbvie.SO has received speaking fees from Asahi-kasei, Eisai, Janssen, and Mitsubishi-Tanabe.SN has received consulting fees, speaking fees, and/or honoraria from Bristol-Myers, Pfizer, GlaxoSmithKline, Sanofi, Chugai, Astellas, Asahi-kasei, and Boehringer Ingelheim and has received research grants from Mitsubishi-Tanabe, Novartis, and MSD.KS declares that there are no competing interests.
